+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The effect of estrogen upon L-DOPA evoked striatal dopamine release in vitro in MPTP-treated female mice



The effect of estrogen upon L-DOPA evoked striatal dopamine release in vitro in MPTP-treated female mice



Society for Neuroscience Abstracts 18(1-2): 1578




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 033772814

Download citation: RISBibTeXText


Related references

Estrogen alters MPTP-induced neurotoxicity in female mice: Effects of striatal dopamine concentrations and release. Journal of Neurochemistry 66(2): 658-666, 1996

Nanomolar L-dopa facilitates release of dopamine via presynaptic beta-adrenoceptors: comparative studies on the actions in striatal slices from control and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mice, an animal model for Parkinson's disease. Japanese Journal of Pharmacology 55(1): 93, 1991

Estrogen reduces MPP+ evoked striatal dopamine release in female, but not male, rats. Society for Neuroscience Abstracts 24(1-2): 356, 1998

Ropinirole, bromocriptine and L-DOPA have a differential effect on striatal dopamine D-2 and D-3 but not D-1 receptor mRNA expression in MPTP-treated marmosets. British Journal of Pharmacology 136(Proceedings Suppl.): 68P, 2002

Estrogen Increases Striatal GDNF Immunoreactivity with no Effect on Striatal FGF-2 Immunoreactivity of MPTP-Treated Mice. Journal of the Medical Association of Thailand 98(Suppl. 9): S16-S22, 2015

Estrogen, but not testosterone, attenuates methamphetamine-evoked dopamine output from superfused striatal tissue of female and male mice. Neuropharmacology 44(5): 624-632, 2003

Estrogen as a neuromodulator of MPTP-induced neurotoxicity: Effects upon striatal dopamine release. Brain Research 764(1-2): 9-16, 1997

Differential effects of ropinirole, bromocriptine and L-DOPA on striatal dopamine D-2 receptor binding in MPTP-treated common marmosets. British Journal of Pharmacology 122(PROC Suppl. ): 315P, 1997

Increased striatal neuropeptide Y immunoreactivity and its modulation by deprenyl, clonidine and L-dopa in MPTP-treated mice. Journal of Neural Transmission 110(12): 1375-1391, 2003

GDNF-induced proliferation of nigral dopamine neurons and reduction of striatal expression of preproenkephalin mRNA in MPTP-treated, L-DOPA-primed common marmosets. British Journal of Pharmacology 126(PROC Suppl. ): 233P, 1999

Amantadine increases striatal dopamine turnover in MPTP-treated mice. Drug Development Research. 29(3): 222-226, 1993

Postsynaptic supersensitivity in striatal D-1 dopamine receptors in MPTP-treated mice. Society for Neuroscience Abstracts 18(1-2): 1577, 1992

Increase of striatal dopamine turnover by stress in MPTP-treated mice. Clinical Neuropharmacology 11(4): 360-368, 1988

Effects of acute and sub-chronic L-dopa therapy on striatal L-dopa methylation and dopamine oxidation in an MPTP mouse model of Parkinsons disease. Life Sciences 110(1): 1-7, 2014

Sex differences in K+-evoked striatal dopamine output from superfused striatal tissue fragments of reserpine-treated CD-1 mice. Journal of Neuroendocrinology 19(9): 725-731, 2007